QCast: Data-Driven Dialogue in Drug Development

Episode 2: Guide to Integrated Summaries of Safety and Effectiveness


Listen Later

In this QCast episode, join Jullia and Tom as they unpack Integrated Summaries of Safety (ISS) and Effectiveness (ISE), breaking down how companies gather data from multiple clinical trials into a single, clear package that regulators need to approve new drugs and devices.

Key Takeaways

  • How pooling trial data uncovers rare safety issues and confirms efficacy.
  • Best practices for standardising data collection and formats early.
  • Strategies for seamless collaboration between statisticians, programmers, and clinicians.
  • How regular double-checks and mock panels prevent regulatory hiccups.
  • Ways a polished summary accelerates approval and optimises labelling.


🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.

About Quanticate

Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:

  • Clinical Data Capture & Management
  • Biostatistics & Statistical Consultancy
  • Statistical Programming & PK/PD Analysis
  • Medical Writing & Pharmacovigilance
  • Regulatory & Submission Support
  • AI & Automation
  • Post-Marketing Safety & Real-World Data

Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

...more
View all episodesView all episodes
Download on the App Store

QCast: Data-Driven Dialogue in Drug DevelopmentBy Quanticate